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Abstract
Background and Objective: Fungal endophyte is a good source in producing bioactive compounds possessing antibacterial, antioxidant
and anticancer activities. This study was aimed to produce fungal endophyte from Phyllantus  niruri  and to test its in  vitro  bioactivity
as antibacterial, antioxidant and cancer cytotoxic agent. The molecular mechanism of  the  fungal  activities  was  then  predicted  using
in  silico  docking. Materials and Methods: Fungal endophyte from genus Trichaptum  sp., isolated from Phyllantus  niruri  herbs was
extracted using ethyl acetate and further fractionated using n-hexane, diethyl ether and ethanol and ethanol 96%  through 
chromatography  column  ready for testing. The antimicrobial test was carried out using disc diffusion method.  The  antioxidant  was 
determined  using  hydrogen peroxide free radical scavenging and reducing power capacity.  The  cytotoxicity  assay against T47D breast
cancer cell was carried out using (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) method. The docking of chemicals
reported in the sample was performed using AutoDock Vina. Results: Diethyl ether fraction was the most active  fraction  against 
Escherichia  coli  and T47D cell growth in a non-toxic dose, whereas the best antioxidant activity was performed by ethanol 96% fraction.
Assays on the cell cycle modulation and its apoptotic behavior suggested that the T47D was disrupted via p53 mutant, Bcl-2 and NF-6B
abrogation. Molecular docking of compounds identified in the fraction suggested that these activities could belong to the maltose binding
perisplasmic and oxydosqualene cyclase inhibition in Escherichia  coli  and T47D, respectively. Conclusion: Fungal endophyte from
Phyllantus  niruri  was successfully isolated as genus Trichaptum  sp. and serving as antibacterial, antioxidant and anticancer activities.
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INTRODUCTION
Endophytes are microsize particles symbiotically living in
between xylem and phloem, leaves, roots,  fruits  and  stems1.
A fungal endophyte was known to produce some biological
active compounds such as alkaloid, terpenoid, phenol, etc.2,
demonstrating antioxidant, anticancer, antibacterial, antiviral,
antifungal  and  antileismanial  activities3.  Previously,
Phyllantus amarus Schum. and Thonn. was identified
depositing classes of endophytic fungi and bacteria, which
lived in between plant cells4. There have been a few recent
studies utilizing fungal endophyte as the sources of  bioactive
compounds from plants and alga such as Pinus strabus5,
Flabellia petiolata6, Nerium indicum7, Taxus8 and Hydrastis
canadensis9.  The fungal endophyte was indicated as much as
10 types in Phyllantus  amarus,  therefore, this herb has been
reported as the resource in producing a fungal endophyte
implemented in drug developments with various biological
activities10.
In   the   same   family   of   Phyllanthaceae,   Phyllantus
niruri Linn., also has a potential to be a new source for
producing a fungal endophyte. Originally, this herb contains
chemical substances including lignin, glycoside, alkaloid,
ellagitannin, terpene, phenylpropanoid, flavonoid, imidazole
and polyphenol11,12. Instead of this herb has been studied its
pharmacological  activity  in  the  treatment  of  bladder
infection, as immunomodulator, anti-inflammatory and
antiviral agents13,14 to date, there is no report about this
species to be used as an endophyte source. Hence, it is
interesting to study more about an extraction and biological
evaluations of the fungal endophyte from this species.
Bacteria resistances in some antibiotics need a high
concern in discovering and developing new antibacterial
which are more susceptible to the mutant and selective to
eradicate the bacteria cells with no effects to the host15.
Subsequently, antioxidant is currently become a hot topic
related with an oxidative stress and a cell damage, indicating
some diseases such as a cancer and coronary heart disorder16.
Furthermore,  a  searching  of  an anticancer that is less toxic
has  been  a lengthy challenge with no results is perfectly
killing the cancer cells without affecting the normal ones17.  In
this present study, it was explore the opportunities of
Phyllantus niruri as the new source for mining the fungal
endophyte in organic fractions  such  as  n-hexane, diethyl
ether  and  ethanol.  These  fractions  were  further  studied its
in  vitro  antibacterial,  antioxidant  and anticancer activities
due to its cytotoxicity effects towards T47D breast cancer cells.
Furthermore, the modulation of a cell cycle leading to
apoptosis by the most active fraction on the T47D was also
investigated. The fungal endophyte was characterized using
both microscopic and molecular genetic analysis to confirm
the genus of the endophyte. Meanwhile, the compounds
contained in the most active fraction were identified using Gas
Chromatography-Mass Spectroscopy (GC-MS).
In rational drug designs, the proteins which are
responsible towards the pathogenesis can be used as the
target in combating the microorganism as well as the malign
cells.  Although we have not tested the fractions against cells
at protein levels due to our limitations, however, it was tried to
gain insight mechanisms of identified compounds in the
endophyte against a diverse protein been expressed in the
most susceptible bacteria and the T47D using molecular
docking.
MATERIALS AND METHODS
Phyllantus niruri leaves were collected from Materia
Medica, Malang, Indonesia with No. of specimen MN 02371.
Potato Dextrose Broth (PDB) was prepared from potatoes
collected from Batu, Malang. Dextrose, muller hinton, Potato
Dextrose  Agar  (PDA),  Nutrient  Agar  (NA)  and  nutrient
broth were purchased from Merck. The microbes were
Escherichia  coli  K-12,  Staphylococcus  aureus  NCTC 8325
and Salmonella thypi  Ty2 purchased from Microbiology
Laboratory, Brawijaya University, Indonesia. All chemicals were
purchased from Merck with analytical grade i.e., sodium
hypochlorite (NaOCl), ethyl acetate, n-hexane, methanol,
chloroform, hydrogen peroxide, phosphate buffer pH 7.0,
potassium iron (III) cyanide, iron (III) chloride, triton-X 100 and
silica 60 for column chromatography. Propidium Iodide (PI) for
cell cycle assay was HPLC grade (Sigma). The T47D cell and
RNase was courtesy from Parasitology Laboratory of Medical
Faculty, Gadjah Mada University, Indonesia. Dulbecco’s
Modified Eagle Media (DMEM), Fetal Bovine Serum (FBS),
penicillin-streptomycin, fungizone and trypsin-EDTA were
purchased from Gibco, whereas tissue culture dish was from
Iwaki. Nucleon PHYTOpure reagents and flow cytometry
annexin V-FLOUS apoptosis detection kit were purchased from
Amersham LIFE SCIENCE and Roche, respectively. The used
instruments were autoclave (AC-300AE, Tiyoda), laminar air
flow cabinet (FARRco), genetic analyzer (ABI PRISM 3130
Applied Biosystems), UV-Vis spectrophotometer (Shimadzu),
GC-MS (AGILENT GC 6890N 5975B MSD), elisa reader (BioRad)
and flow cytometer (FACTS).
Isolation: A surface sterilization was used for the isolation of
the  fungal  endophyte  according  to  Kumar et al.18  method.
To  eliminate  the  epiphytic  microflora  and  parasite from  the
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sample’s leaves, a sterile distilled water was used by washing
and shaking them for 1 h. The healthy leaves were soaked
using ethanol 70% for 2 min, followed by 1%  of  NaOCl
solution for another 3 min. These were then rinsed in re-
distilled and sterilized waters for a couple minutes. Leaves
were dried on a blotting sheet followed by taking the imprints
from  the  media  plates.  Finally, samples were chopped onto
10 mm  of  segment’s  diameter and placed them (five
segments on each plate) onto petri dishes containing PDA
(supplemented with 100 mg mLG1 of chloramphenicol). This
was then incubated at 25EC until the growth of endophytic
fungi was discerned. After two weeks, hyphae were inoculated
on PDA plates at 28EC for a puri cation.  Each fungal isolate
was checked for their purity and transferred into the new
medium using the hyphal tip method. The mycelial tips were
transferred into the PDA plates. This puri cation method was
repeated for more than  ve times. Mycelia were then stored in
a sterile test tube slant. One of the isolates coded as BJ was
then selected for further molecular identifications.
Molecular genetic analysis: The identification of fungal
isolates was carried out at a molecular level based on a partial
genetic analysis at Internal Transcribed Spacer (ITS) of the
fungal ribosomal DNA. The DNA isolation was initiated by
growing the fungi isolate in PDB and then incubated for 72  h.
A  biomass  of  fungal  mycelia  was  subsequently  harvested
for  DNA  extraction  process.  Fungal  DNA  was  extracted
using  nucleon  PHYTOpure  reagents.  The  PCR  amplification
was carried out using primary19,20 ITS 4: 5`-TCCTCCGCTTAT
TGATATGC-ITS   3`   and   Primary   5:   5`-
AAAAGTAGTCGTGGAAACAAGG-3`. The PCR product was
purified using PEG precipitation method21 followed by a cycle
sequencing. The results of the cycle sequencing were purified
back using ethanol purification method. The sequence of
nitrogen bases was read using an automated DNA sequencer.
The raw data of the sequence was then trimmed and
assembled   using   bioedit program (http://www.mbio.ncsu.
edu/BioEdit/bioedit.html).  The  assembled  sequence  was
BLAST-ed using genomic data, which  has  been  deposited  in 
DDBJ/DNA  Data  Bank  of Japan  (http://blast.ddbj.nig.ac.jp/) 
or  NCBI/National  Center for Biotechnology Information
(http://www.ncbi.nlm.nih.gov/ BLAST/) to determine the
taxon/species based on the highest homology with the
reference.
Tissue culture: The colony of fungal endophytes was taken
from PDA using ose to have 5 plugs with 0.5 cm in diameter.
A volume of 200 mL of the colony was inoculated into a
sterilized   conical   flask   and   then    incubated    at    a    room
temperature  for  14  days. The  mycelium  was  then   collected
from the filtrate by a filtration, followed by drying them at
50EC. Thereafter, the dried mycelium was then pulverized.
Extraction: The mycelium powder was macerated using ethyl
acetate (1:3) for 48 h with a frequent agitation. The liquid
extract was then filtrated and the residue was re-macerated
using new ethyl acetate for 24 h with the same frequent
agitation. The filtrate was then collected and concentrated
under a reduced pressure.
Fractionation: The concentrated extract (200 mg) was then
fractionated using 200 µL of each n-hexane (100%), diethyl
ether (100%) and ethanol 96% through a chromatography
column with an isocratic technique. Each fraction was
collected and concentrated under a reduced pressure
followed by drying them at 50EC.
Antimicrobial test: The antimicrobial test was carried out
using a disc diffusion (Kirby-Bauer test) method22, whereas the
Minimum Inhibition Concentration (MIC) was performed using
a micro-dilution test23.
Screening  of  active  fractions: The series of concentrations
for each fraction was prepared to have 100, 50, 25, 12.5 and
6.25 µg mLG1 of  working solutions. Ten microliters of each was
dropped into a paper disc to have amounts of  the isolate for
each paper disc, i.e., 1000, 500, 250, 125 and 62.5 µg mLG1.
These were left to dry up to the paper disc being attached to
the media. Streptomycin 10 mg mLG1 (10 µL) and a sterile
anhydrous ethanol were used as the positive and the negative
control, respectively. The bacterial culture was then incubated
at 37EC for 18-24 h followed by viewing the inhibition zone
around the paper disc. Subsequently, the widest diameter of
the inhibition zone was selected as the active fraction.
Determination  of  Minimum  Inhibition  Concentration
(MIC): A volume of 50 µL of Muller Hinton media was
transferred into 96-microwell plate, followed by adding 50  µL
of the bacterial suspension, which have been adjusted its
turbidity based on McFarland standard 0.524.  This mixture was
then diluted up to 10 times, therefore, the final concentration
would be 250, 125, 62.5, 31.25, 15.63, 7.81 and 1.96 µg mLG1.
Streptomycin 10 mg mLG1 was used as the positive control.
The sample was then incubated at 37EC for 18-24 h and the
cell density was measured as absorbance using microplate
reader at 595 nm. The absorbance were converted into
percentage   inhibition   and   then   extrapolated  against  the
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concentration of the active fraction. The IC50 of the fraction
was then calculated and analyzed according to Probit
analytical method managed by Minitab software
(www.minitab.com). The MIC measurement was performed by
pipetting 3 µL of  the  solution from each well to be streaked
on the NA without addding the microbes and working
solution. If only the streaked media being clear after 18-24 h
of the incubation at 37EC, the MIC value was defined.
Determination of a total phenolic content: The total
phenolic content was determined using Folin-Ciocalteu
reagent with galic acid as  the  reference25.  Each of  fractions
was dissolved into methanol to have 2 mg mLG1 of
concentration followed by adding 500 µL of Folin-Ciocalteu
(50%) and 2 µL of Na2CO3 20%. This mixture was top up with
5 µL of distilled water and then stored at a room temperature
for  20  min,  followed by reading its absorbance at 765  nm.
The total phenolic content was observed based on the
absorbance to the linear regression equation generated from
the galic acid standard curve (30, 45, 60, 75 and 90 µg mLG1).
Determination of  antioxidant activities: Two methods were
used in determining the antioxidant activities of the fractions,
i.e., hydrogen peroxide free radical scavenging3 and reducing
power capacity26.
Hydrogen peroxide free radical scavenging: A solution of
hyrogen peroxide (40 mmol LG1) was prepared using
phosphate buffer pH 7.5. The fraction was dissolved into a
distilled water to have 2 mg mLG1 of  concentration and then
added with H2O2 solution. After 10 min of the reaction, the
sample was read its absorbance at  230  nm.  The capacity of
the fraction to scavenge the H2O2 radical was calculated based
on the formula as followed:
(Ai-At)Scavenging capacity (%) = 100
Ai

where, Ai is absorbance of the control and At is absorbance of
the sample.
Reducing power capacity: Each of fractions was dissolved
into 1 mL of a distilled water and then mixed up with 2.5 mL
of  phosphate buffer pH 6.6 and 2.5 mL of  potassium iron (III)
cyanide  1%  w/v.  The  mixture  was  then  centrifuged  at
3000 rpm for 10 min. The upper phase was taken 2.5 mL and
then added with another 2.5 mL of a distilled water, followed
by adding 0.5 mL of  FeCl3 0.1% w/v.  The  absorbance  was
then measured at 700 nm using UV spectrophotometer.
T47D cell assays
Cytotoxicity assay: The cytotoxicity assay of the fraction
against   T47D   breast   cancer   cell   was   carried   out   using
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) method27. The T47D cell was cultured on the RPMI
media,   whereas   the   normal   cell   (Vero)   was   cultured   on
the  M199  media.  Each  of  them  contained  FBS  10%,
penicillin-streptomycin 1% and fungizone 0.5%. A series of
working solution was prepared with concentrations as
followed: 7.81, 15.62, 31.25, 62.5, 125, 250 and 500 µg mLG1,
meanwhile cisplatin (15 µM) was used as the positive control.
The cell viability was determined at 595 nm and the
absorbance was converted into the percentage viability using
a plate reader. The IC50 was calculated by plotting the
percentage viability against the concentration of the fraction.
Subsequently, the Selectivity Index (SI) was defined according
to the ratio between  the  IC50  of  vero cell and  the  IC50  of
T47D cell.
Apoptotic     observation:     Thousand     microliters     of
5×105 cells/well was seeded into 6-well plate and then
incubated for a week. Two separate cells were treated with
900 µL of the diethyl ether fraction and cisplatin, respectively
with the selected concentrations based on the cytotoxicity
assay. For the negative control, the same volume of a cultured
medium was added and then incubated for 24 h. The medium
was then transferred into a conical, washed using 500 µL of
PBS and harvested by adding 200 µL of  trypsin-EDTA 0.25%.
This was followed by incubation for 3 min to let the cell
detached from the bottom of the plate. The culture medium
1000 µL mLG1 was added while re-suspending the cells to be
transferred to the same conical. The cells were then
centrifuged (2000  rpm,  5 min) and the media were discarded.
The precipitated cells were collected and then dissolved in
annexin  V-FLOUS  kit  buffer  followed  by  adding 2 µL of  PI
and 2 µL of annexin V. The cells suspension was then
homogenized over 10 min at a room temperature and
transferred to the flow cytometric tube for apotoptic
observation.
Cell cycle observation: The same procedure with the previous
apoptoptic assay preparation was applied, but a little bit
difference was made after washing the precipitated cells using
a cold PBS. The cells were then added with flow cytometric
reagent composed of 25 µL of PI, 1 µL of RNase and 0.5 µL of
triton-X. The mixture was then topped up to 500 µL using PBS
for each sample. The cells suspension was re-homogenized
and then transferred into the flow cytometric tube. The
sample was then analyzed using flow cytometer to  determine
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the cell cycle profile. The flow cytometric data was analyzed
using flowing program to visualize the cells distribution at
each phase of the cells cycle.
Structural identification of the most active fraction: The
structural identification of the most active fraction was carried
on GC-MS. For this 1 mg of fraction was dissolved in 1 mL of
dichloromethane. The Rtx®-50 column (30×250×0.25 µm)
was used as the stationary phase with helium as a carrier gas
at a flow rate of  1 mL minG1 and a pressure of  8.80 psi. The GC
oven temperature was kept at 70EC and 300EC for initial and
final  temperature,  respectively.  The  temperature  rate
incrase was set at 10EC minG1 during 15 min. Splitless
injections  were  implemented  with  liquid  injection  method
in this experiment. A library search for the structural
identification was carried out using Wiley 7 Nist05 library
(http://www.sisweb.com/software/ms/wiley.htm).
Molecular docking: The in silico prediction of chemical
substances which were identified in GC-MS for the most active
fraction carried out by docking the compounds into 10
representative protein targets from the selected bacteria and
T47D cells, respectively. The ligands were sketched and
geometrically minimized using ACD Chemsketch
(www.acdlabs.com) and Marvin Sketch (www.chemaxon.com),
respectively. The ligands and proteins were then prepared
using AutoDockTools 1.5.6 (www.autodock.scripps.edu). The
proteins were added with polar hydrogen and given by
Kollman charge, whereas the ligands were given by Gasteiger
charges. The grid was centered on each protein binding site
and the docking was then performed using AutoDock Vina
embedded in PyRx version 8.0 (www.autodock.scripps.edu).
The hit of  protein was selected based on the lowest mean of
free energy of  binding (Gbind),  whereas  a  combination of  a
low Gbind and hydrogen bond (H-bond) interaction was
considered  to  select  the  hit  of  ligand.  The  selected
docking pose was visualized using discovery studio 3.5
(www.accelyrs.com).
RESULTS AND DISCUSSION
Fungal endophyte culture: A fungal endophyte namely
Trichaptum  sp.  (Fig.  1a)  which  was   isolated   from
Phyllantus  niruri  leaves, physically characterized as a white
fungal colony (Fig. 1b). The fungal morphology was identified
by Mycology Laboratory, Agriculture Faculty (Gadjah Mada
University, Indonesia) 45, stated that the sample had
characteristics as followed:  A helix solid mycelium, composed
of dark hyphae pigmen and having uniform sclerotia. For
instance, these characteristics were microscopically equal to
the genus of  Trichaptum  sp., as described by the literature28.
The ethyl acetate extract of the fungal endophyte was
collected in a considerably high yield (40%), therefore this is
potential to be a good source of producing bioactive
compounds.
Fungal molecular ecology needed the biggest sequence
of  DNA region to have a universal barcode sequence. The ITS
gene for fungi was an important tool to precisely identify the
molecular  systematic  of the tested fungal sample at genus
and even species levels. The BLAST analysis of rDNA gene
sequences   of   ITS   demonstrated   the   highest  similarity
with  Trichaptum  sp.,  with  percentage  of  homology  was
99% towards  a  unique  identifier  utilizing Trichaptum  sp. 
E7082 from  the  repository.  Hence,  based  on  the  molecular
Fig. 1(a-b): (a) Fungal culture of  Trichaptum  sp.,  in  14th  day  of  incubation and (b) The morphology of  Trichaptum  sp., with
7 days in age
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Table 1: Sequence of ITS rDNA isolate (coded as BJ) and the BLAST result of the most similar taxon
ITS_4_Reverse
ATTGTCAAAGTATTTGTCTCGAGAGAGACGGCTAGAAGCGTGAATTCAATAAATACTTCACCACCGCAGC
CAGATAATTATCACACTGAAGGCGATCCGTAAGGTTCACACTAATGCATTTCAGAGGAGTCGACTGGCGA
AGCCGACACAGCCTCCAAGTCCAAGCCCACCAAATCTTTACTAGAAAAATTCAGGGGTTGAGAATACCATGAGACTCAAACAGGCATACTCCTCGGAATACCAAGGAGTGCAAG
GTGCGTTCAAAGATTCGATGATTCACTGAATTCTGCAATTCACATTACTTATCGCATTTCGCTGCGTTCTTCATCGATGCGAGAGCCAAGAGATCCG
TGCTGAAAGTTGTATATATTGTGTTATACACAGTGTACATTTATAACTGAAGTGTTTGTGGTAAAACGCAAGAGAAGGCTTGTCACTGACTTTTTACAAGATCAGCTTACACCGCTCT
CTTACATGAAGTGCACAGAGGTT
 AGAGTGGATGAGCCAGGCGTGCACATACCCCAAAAAGAGGTCAGCTACAACCTGTTCAAAAACTCGATAATGATCCTTCCGCAGGTTCACCTACGGAAACCTTGTTACGACTTTTACTC
ITS_5_Forward
TTATCGAGTTTTTGAACAGGTTGTAGCTGACCTCTTTTTGGGGTATGTGCACGCCTGGCTCATCCACTCTCAACCTCTGTGCACTTCATGTAAGAGAGCGGTGTAAGCTGATCTTGTA
AAAAGTCAGTGACAAGCCTTCTCTTGCGTTTTACCACAAACACTTCAGTTATAGAATGTACACTGTGTATAACACAATATATACAACTTTCAGCAACGGATCTCTTGGCTCTCGCATC
GATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACCTTGCACTCCTTGGTATTCCGAGGAGTATGCCTGTTTGAGT
CTCATGGTATTCTCAACCCCTGAATTTTTCTAGTAAAGATTTGGTGGGCTTGGACTTGGAGGCTGTGTCGGCTCTCGCCAGTCGACTCCTCTGAAATGCATTAGTGTGAACCTTACG
GATCGCCTTCAGTGTGATAATTATCTGCGCTGCGGTGGTGAAGTATTTATTGAATTCACGCTTCTAGCCGTCTCTCTCGAGACAAATACTTTGACAATCTGAGCTCAAATCAGGTAG
GATTACCCGCTGAACTTAAGCATATCAATA
Contig-sample
TTATCGAGTTTTTGAACAGGTTGTAGCTGACCTCTTTTTGGGGTATGTGCACGCCTGGCTCATCCACTCTCAACCTCTGTGCACTTCATGTAAGAGAGCGGTGTAAGCTGATCTTGTA
AAAAGTCAGTGACAAGCCTTCTCTTGCGTTTTACCACAAACACTTCAGTTATAGAATGTACACTGTGTATAACACAATATATACAACTTTCAGCAACGGATCTCTTGGCTCTCGCATC
GATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACCTTGCACTCCTTGGTATTCCGAGGAGTATGCCTGTTTGAGT
CTCATGGTATTCTCAACCCCTGAATTTTTCTAGTAAAGATTTGGTGGGCTTGGACTTGGAGGCTGTGTCGGCTCTCGCCAGTCGACTCCTCTGAAATGCATTAGTGTGAACCTTACG
GATCGCCTTCAGTGTGATAATTATCTGCGCTGCGGTGGTGAAGTATTTATTGAATTCACGCTTCTAGCCGTCTCTCTCGAGACAAATACTTTGACAAT
E7082: Coded for Trichaptum sp., a spesies used as the reference, AJ536658: The code to acces in DDBJ or NCBI, Trichaptum  sp., E7082 (Accession no: AJ536658),
Homology: 99%, Max score: 1040, Total score: 1040, Query coverage: 100%, E-value: 0.0, Max identities: 566/567 (99%) and Gaps: 1/567 (0%)
Table 2: Results of the disc diffusion assay of the fractions against the bacteria
Growth inhibition zone (mm)
--------------------------------------------------------------------------------------------------------------------------------------------------
Fraction Loading (µg) Staphylococcus aureus Escherichia coli Salmonella thypi Positive control Negative control
n-hexane 62.5 ND ND ND 23 ND
125 ND ND ND
250 ND ND ND
500 ND ND 2
1000 5 7 3
Diethyl ether 62.5 1 ND 3 20 ND
125 4 4 5
250 5 5 5
500 7 9 7
1000 14 11 13
Ethanol 96% 62.5 ND ND ND 17 ND
125 ND ND ND
250 ND ND ND
500 ND 1 9
1000 2 4 11
ND: Not detected
genetic analysis, the fungal endophyte was confirmed its
genus as Trichaptum  sp.  The  sequence of  ITS rDNA isolate
and  the  BLAST  result of the most similar taxon were
presented in Table 1.
Screening of active fraction: The preliminary determination
of antibacterial activities of the fractions was necessary to
select which fraction would be potential for further testing.
Table  2   presented   the  inhibition  zone  of  three  fractions
(n-hexane, diethyl ether and ethanol 96%) towards S.  aureus,
E. coli and S. thypi. As results, diethyl ether fraction
demonstrated a higher inhibition towards the bacterial
growth than other two fractions. In the lowest concentration
(62.5  µg mLG1), diethyl ether fraction inhibited both S.  aureus
and S. thypi, whereas neither n-hexane nor ethanol 96%
fractions performed any inhibition. The inhibition of all
bacteria  by  diethyl  ether  fraction  was  observed  at
concentration 125 µg mLG1, since then the inhibition was
proportionally increased along with the higher concentration
of  the fraction. Towards this fraction, all bacteria are similarly
susceptible  as  shown  by  its  close values of  the inhibition
zone  starting  from  125-1000  µg  mLG1.  On  the  other  hand,
n-hexane and ethanol 96% fractions were more likely
susceptible   towards  E.  coli   and  S.  thyphi,  respectively  as
shown by its higher inhibitions at 1000 µg mLG1. Although,
they    can    strongly    inhibit    the   bacteria   at   the   highest
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concentration only, however, it was decided to include them
for further IC50 calculations due to its potential antimicrobial
activities to more specific bacteria as discussed.
Minimum Inhibition Concentration (MIC) and IC50
calculation:     The     potent    fraction    was    justified    from
its capability to inhibit the bacteria at the minimum
concentration. When the fraction was able to inhibit at least
50% of the bacterial growth, only the IC50 value would be
defined. Table 3 presented the MIC and IC50 value of each
fraction against three bacteria. According to the susceptibility,
the diethyl ether was the best fraction due to its capability to
inhibit all bacteria at a lower concentration than two other
fractions. The diethyl ether fraction has less than 100  µg mLG1
of  IC50 to all bacteria indicating its broad spectrum activity.
The E. coli was the most susceptible bacteria towards the
diethyl ether fraction as it  showed  the  lowest  IC50  value
(23.98 µg mLG1) among three bacteria. Either n-hexane or
ethanol 96% was less sensitive than diethyl ether, as shown by
its IC50 value with more than 100 µg mLG1. However, as
indicated in the preliminary antibacterial assay, ethanol 96%
fraction selectively inhibited S. thyphi more than other
bacteria due to its IC50 value i.e., 98.11 µg mLG1, which was
potential for a narrow spectrum antibacterial. The least
susceptible fraction was detected on n-hexane as it showed
more than 100 µg mLG1 of IC50 to all bacteria.
Total  phenolic  content:  The  total  phenolic  content  is
associated with the reducing capacity of the compounds
under redox reactions. Table 4 presented the total phenolic
content of the three fractions which was found in a quite
broad range. Having its polar character, phenolic compounds
were more soluble in a polar solvent  such  as  ethanol 96%
than in semipolar (diethyl ether) and nonpolar (n-hexane)
solvents. However, in the diethyl ether, the total phenolic
content was quite high that might contribute in the bacterial
inhibition as known that phenol could denature the protein
leading to a bacterial eradication29.
Antioxidant  activity:  Hydrogen  peroxide  is  rapidly
decomposed into oxygen and water. This may form hydroxyl
radical able to modulate the lipid peroxidation process lead to
the cell damage.  In this assay,  all fractions possessed the free
radical scavenging activity at 34-85% (Fig. 2a). Among all
fractions, ethanol 95% demonstrated the highest radical
scavenging (85%) which was almost comparable with vitamin
C (95%) as the positive control. This was in agreement with the
reducing power capacity assay (Fig. 2b) which demonstrated
the same order for all three fractions.  The  ethanol 96%
fraction was able to reduce the reduction of  Fe (III) to Fe (II) in
such a way that those compounds donated electron to
stabilize the radicals up to 80% in the ethanol, which was
almost comparable to that vitamin C (90%). These two
antioxidant activities corresponded to the total phenolic
content,  in which ethanol as a polar solvent able  to  strongly
Fig. 2(a-b): Antioxidant activity of three fractions using
methods,  (a)  H2O2  free  radical  scavenging  and
(b)   Reducing   power   capacity,   A:   Vitamin   C,
B: n-hexane   fraction,   C:   Diethyl   ether   fraction
and D: Ethanol 96% fraction. The graph was
prepared using Microsoft Excel 2010
(www.microsoft.com)
Table 3: IC50 and MIC value of three fractions against Staphylococcus  aureus,
Escherichia  coli  and Salmonella  thypi
Samples
--------------------------------------------------------------------------------------
n-hexane Diethyl ether Ethanol 96%
------------------------ --------------------- -----------------------
IC50 MIC IC50 MIC IC50 MIC
Bacteria ------------------------------------  (µg mLG1) -----------------------------------
E. coli 111.23 >500 23.98 125 102.34 >500
S. aureus 245.76 >500 60.14 250 107.98 >500
S. typhi 113.09 >500 45.11 125 98.11 >500
Table 4: Total phenolic content of three fractions
Fraction Total phenolic content (mg GAE gG1 fracton)
n-hexane 13.14±0.43
Diethyl ether 56.98±0.11
Ethanol 96% 65.70±0.87
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Fig.  3(a-b): Drug-dose response curve of  diethyl ether fraction against the percentage viability of (a) T47D and (b) Vero cell with
p<0.05. The graph was prepared using Microsoft Excel 2010 (www.microsoft.com)
Fig. 4(a-f): Effect of diethyl ether fraction towards T47D73 and vero cells (d-f). The viewing was performed under inverted
microscope with 100x of magnitudes, (a) Negative control (b) Diethyl ether fraction 5 µg mLG1, (c) 10 µg mLG1, (d)
Negative control, (e) Diethyl ether fraction 250 µg mLG1 and (f) Diethyl ether fraction 500 µg mLG1. The arrow indicated
the living cell whereas the dashed arrow indicated the morphological alteration
Table 5: Results of cytotoxicity assay against T47D cell line 
Fractions IC50 T47D (µg mLG1) IC50 vero (µg mLG1) Selectivity Index (SI)
n-hexane 92.64±0.76 245.98±1.65 2.66
Diethyl ether 13.07±0.23 230.87±0.96 17.66
Ethanol 96% 67.56±2.34 339.32±1.65 5.02
fractionate phenolic based compounds. This antioxidant
activity could be associated with a lipid peroxidation
inhibition.
T47D cell assay
Cytotoxicity assay: The T47D is breast cancer cell lines, which
is primarily used as the model in a breast cancer research30.
The inhibition of this cell up to 50% was associated with the
potential anticancer from the fractions (Table 5).  All fractions
were observed having IC50 less than 100  µg mLG1  indicating
its   potential   as  an  anticancer  with  diethyl  ether  fraction
re-showing the lowest IC50 value than two others. Fortunately,
this fraction showed the highest Selectivity Index (SI)
indicating its selectivity was rather to cancer than the normal
cells. There have been an agreement between antibacterial
and cytotoxicity assays, hence, this fraction was promiscuous
for chemotherapeutics against both bacteria and cancer cells.
Figure 3a and b plotted the concentration of diethyl ether
fraction against the percentage inhibition of  T47D cell line
and vero cell, respectively.
The morphology of T47D upon diethyl ether exposure
was observed altering the cell being shrunk, died and reduced
in the cell number. These effects were verified by comparing
them with the negative control, in which the cell without
treatment   had   no   morphologic  alteration  (Fig.  4a-c).  The
8
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Fig. 5(a-c): Flow cytometry detection of cells cycle distribution, (a) Negative control, (b) Cisplatin and (c) Diethyl ether fraction
treatment. In 6-well plate, 5×105 cells was cultured and incubated for 24 h in high glucose DMEM either with or
without treatments. The detection of flow cytometri was done using PI reagent towards T47D cell after 4 µg mLG1 of
diethyl ether fraction dan 2.5 µM of cisplatin exposure or the combination of its all three components, G0 is a phase
that cell preparing to enter the G1 cell cycle
Table 6: Percentage of cells cycle distribution after diethyl ether and cisplatin
exposure towards T47D cell
Samples G1 phase (%) S phase (%) G2/M phase (%) CV (%) G1 phase (%)
Negative 48.65 11.87 24.75 8.87 48.65
control
Cisplatin 41.86 13.12 27.54 9.45 41.86
Diethyl 25.87 27.43 17.40 6.87 25.87
ether fraction
cytotoxic effect of diethyl ether fraction towards vero cells
based on IC50 value as well as the morphology profile, showed
a milder effect than T47D cells. However, the diethyl ether
fraction exposure altered the morphology of the Vero cell to
be shrinking, circling and detaching from the bottom of the
well although it needed more concentrations to give the same
effect with that of T47D (Fig. 4d-f).
Modulation of T47D cell cycle: As occurred in normal cells,
the DNA synthesis in cancer ones also went through the cells
cycle. One of the main targets in blocking the cancer cells
proliferation was done by modulating the cells cycle, which
could be observed using flow cytometric method. Flow
cytometry was able to detect every single phase in the cells
cycle based on chromosome numbers for each phase (G1, S
and G2/M). The G1 phase had 2n (diploid) chromosome,
whereas S phase replicated them as the preparation to enter
G2 phase.  The  number  of  chromosome  sets  in  this  stage
was  between  2n  and 4n, meanwhile G2 phase formed 4n
(two diploid cell) chromosome31. The flow cytometric analysis
using flowing program was presented in Fig. 5 and its detail
cells cycle percentage could be seen in Table 6.
The negative control was distributed over G1, S and G2/M
phases. The result showed that cisplatin caused the cell
accumulation at the S phase.  Likewise, diethyl ether  fraction
caused the cell accumulation at the S phase compared to the
negative control. In the treatment of diethyl ether fraction, the
percentage of cells cycle distribution at the S phase was
observed as 27.43%, which even higher than a single cisplatin,
noted as 13.12%. It was found an increment on cells
accumulation at the S phase for diethyl ether fraction
compared to that negative control as nominally observed
from 11.87-27.43%. This might happen because of cell cycle
arrest at that stage.
The treatment of diethyl ether fraction at the lowest
concentration did not cause cell death and even badly
increased the cell population at the S phase. It was known that
the cell cycle progress was activated sequentially from cyclin
or CDK complex which was specific in each cell cycle phase. In
both G1 dan S phases, the cell regulation was inhibited by
cyclin-dependent kinase inhibitor (CKI) such as protein of INK4
and CIP/KIP along with tumor suppressor genes, including pRB
and p53.  In this study,  the  mutated  T47D at p53 was utilized,
so that the anticancer mechanism of  diethyl ether fraction
could posses via p53 independent pathway. 
The independent pathway from p53 status and S arrest
case might happen because a rapid decline of Cdc25A
phosphatase activity, which was impacted by the
ubiquitination along with its degradation by proteosome. This
decline failed to activate CDK2 kinase by inhibiting its
dephosphorilation at Thr14 and Tyr15. The phosphorilation of
Cdc25A was mediated by ATM/ATR-Chk2/Chk1 cascade
pathway32,33. The degradation of Cdc25A phosphatase was
dependent to ATM-Chk2. This ATM-Chk2 inhibited CDK2,
which shall initiate Cdc45 (replication checkpoint) leading to
a DNA replication speed reduction. This then stopped the DNA
replication and triggered the S arrest34.
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Fig. 6(a-c): Effect  of  apoptotic  induction  after  diethyl  ether  and  cisplatin  treatment,  (a) Negative control, (b) Cisplatin and
(c) Diethyl ether fraction treatment. Cells were cultured with 5×105 density in 6-well plate and incubated  for 24  h
in high glucose DMEM with and without treatment, R1, R2, R3 and R4 quadrant located the survived cell, initial
apoptosis, final apoptosis and necrosis, respectively
Table 7: Percentage of cell death after diethyl ether and cisplatin exposure
towards T47D cell
Negative Diethyl ether fraction Cisplatin
Parameters control (%) (4 µg mLG1) (%) (2.5 µM) (%)
Initial apoptosis (%) 1.43 8.89 2.65
Final apoptosis (%) 1.09 1.34 2.98
Necrosis (%) 0.87 1.65 1.02
Total 3.39 11.88 6.65
The p38MPK pathway also took the role in the cell cycle
inhibition  at  the  S  phase,  which  could  be going through
p53-independence. Protein p38 could directly phosphorilate
and stabilize an in  vivo  p2135. Likewise, p38 protein also could
phosphorilate and promote the degradation of  Cdc25A which
contributed in stopping the cell cycle at the S phase36.
In the p53 mutated tumor cell, it was known about the
response reduction towards agents which induced apoptosis,
thus, could serve as the antineoplastic agent working on a
resistant DNA damage. This mutation will cause a failure of a
chemotherapeutic agent such as doxorubicin in activating p53
via DNA intercalation as well as its interaction with
topoisomerase IIa. The T47D cell could be resistant towards
doxorubicine due to the mutated p53 gen37,38. This opened the
chance of the diethyl ether fraction at a lower dose could be
developed as a co-chemotherapeutic agent.
The anticancer activity of the diethyl ether fraction
serving as a cell arrest inductive agent at the S phase could be
developed by introducing  it  with an arrest  damaging  agent.
When the p53 deficient cancer cell was introduced by the DNA
damaging agent in combination with a checkpoint ruining
agent at the S phase, the cell would be triggered to enter the
mitosis phase while carrying the damage DNA ending to an
apoptosis and cell deaths (a mitotic catastrophe).
The mechanism via this checkpoint impairment was
believed as one of the strategies to selectively kill the cancer
cells. These cells were suffering defect on p53 gen but at the
same time, the normal cells were still protected having wild
type p53 gen39-41. A few compounds have been reported as
the S checkpoint abrogator such as AZD7762 worked by
inhibiting phosphorylation of Cdc25A. This phosphorilation
was done by Chk1 and Chk2 using gemcitabine as the S arrest
inductor42.
Apoptosis of T47D cell: The cells death being caused by
apoptosis or necrosis could be differentiated using Propidium
Iodide (PI) coloring agent via a  DNA  intercalation43  (Fig. 6).
The apoptotic induction resulted a percentage of cell death,
which was affected by the treatments of either diethyl ether
fraction or cisplatin presented in Table 7.
The result showed that without any treatment, the T47D
cell could be survive up to 96.61% of living cells and it was
only 3.39% of cell deaths being observed. The treatment using
diethyl ether fraction was found to increase the T47D cell
deaths percentage up to  11.88%,  even  better  than  cisplatin
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Fig. 7: GC chromatogram of diethyl ether fraction of the fungal endophyte
which could kill the cells up to 6.65% only. This suggested that
the diethyl ether fraction could be more potent than that of
positive control.
The T47D was a breast cancer cell having caspase-3 wild
type, caspase-7 wild type, ER/PR positive and p53 mutant44.
Cisplatin was reported able to induce Bcl-2 downregulation on
the T47D breast cancer cell45 and also to form a DNA crosslink
causing DNA damages leading to apoptosis46. The Bcl-2
downregulation (antiapotoptic protein) would decrease the
cell defense, therefore it increased the susceptibility towards
chemotherapeutic agent47. The diethyl ether fraction was
found to increase apoptosis and undergo the cell cycle
modulation at the S phase. This caused the cell being failed to
replicate and stop the proliferation. However, there might
happen intermolecular antagonisms among compounds in
the diethyl ether fraction, therefore, further study was
necessary to investigate the individual apoptotic induction for
each compounds identified in the fraction. Moreover, it is well
studied that the apoptosis could be induced via NF-6B
inhibition, a protein complex that controls transcription of
DNA, cytokine production and cell survival. The proteins such
as p53 mutant, Bcl-2 and NF-6B which could be involved in
such molecular mechanism should be more specifically
discussed.
Structural identification of the most active fraction: The fast
structural identification of compounds in diethyl ether as the
most active fraction using GC-MS, revealed five compounds at
different retention times (Rt) with higher peak intensities than
others in the GC chromatogram (Fig. 7). These compounds
were identified based on their MS profile including the
matched molecular weight as well as its fragmentation with
compounds database in Wiley 7 Nist05 library. Five
compounds with molecular weight (m/z) 256 (15%), 282
(22%), 414 (4.5%), 468 (4%) and 156 (12%) were identified as
hexadecanoic  acid  (1;  Rt  17.507  min),  9-octadecanoic  acid
(Z)  (2; Rt 19.187  min),  gamma  sitosterol (3; Rt 29.175 min),
9,19-cyclolanost-24-en-3-ol acetate (4; Rt 31.740 min) and
dihydrolinalool (5; Rt 32.597 min), respectively. Instead of  GC
only detected compounds in high intensities for the volatile
ones which usually have more hydrophobic characters,
another  9  compounds  with  very  low   intensities   (<1%)
were also observed (Table S1). These compounds were
characterized having more drug-like structures according to
the Lipinski  rule  of  five48 than the previous ones. These
compounds might be low detected in GC because they were
less volatile due to the presence of hydrophylic functional
groups. In contrast, they could highly present if other
identification method such as LC-MS were used. Therefore, we
included  them in the list of compounds for further study on
in silico protein-ligand interactions.
Molecular docking
In  silico  activity against protein targets in E.  coli:  There
have been more than 4,000 Open Reading Frames (ORFs)
characterized in the E. coli  genome,  encodes  approximately
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Table S1: Compounds have been identified from diethyl ether fraction of the fungal endophyte
Codes Rt (Min) Molecular weight Names (Molecular weight) Structures
6 12.548 136 m-aminobenzaldehyde oxime
N
H N2
OH
7 12.806 106 4-sulfanyl-1-butanol
HO
SH
8 23.554 207 4,7,7-trimethylbicyclo[2.2.1]heptan-2-one O-allyloxime H C3 CH3
N O
CH2
CH3
9 26.443 207 2-ethylacridine
N
CH3
10 26.807 222 2,4-cyclohexadien-1-one, 3,5-bis [1,1-dimethylethyl]-4-hydroxy
OH
O
CH3
CH3H C3
CH3
CH3 CH3
11 27.293 207 Cyclohexanecarboxamide, N-furfuryl
O
O
NH
12 28.545 207 N-ethyl-1.3-dithioisoindoline
CH3
S
N
S
13 31.080 355 2’,4’-dimethyloxanilic acid N’-veratrylidenehydrazide CH3
CH3 CH3
H C3
O
O
O
O
NH
N
HN
12
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Table S1: (Supplementary data continued)
Codes Rt (Min) Molecular weight Names (Molecular weight) Structures
14 32.081 207 2-[4’-dinitro-3’-thienyl]pyrimidine O O
NN
N
S
+
-
Table 8: Gbinding of 14 ligands were docked into 10 proteins in Escherichia  coli
Gbind (kcal molG1)
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Ligands 1I52 1JVY 1MOS 1SZS 4DUH 1I30 1JZQ 1IX6 1OHA 2PTH
1 -4.6 -6.5 -5.6 -5.3 -5.9 -5.3 -5.3 -4.5 -5.0 -5.1
2 -4.9 -6.9 -4.6 -6.4 -6.6 -5.4 -5.4 -5.1 -5.8 -4.7
3 -6.4 -9.6 -8.0 -7.7 -6.3 -7.9 -7.7 -7.1 -7.7 -5.5
4 -6.8 -10.7 -6.7 -8.5 -5.5 -8.7 -9.3 -8.0 -8.3 -5.1
5 -5.2 -6.6 -4.8 -5.8 -5.4 -5.2 -5.6 -4.9 -5.0 -4.9
6 -5.3 -6.0 -5.6 -6.5 -6.1 -5.9 -5.4 -6.0 -6.2 -5.1
7 -3.2 -3.5 -3.5 -4.0 -3.7 -3.3 -3.3 -3.4 -3.5 -3.1
8 -6.2 -7.3 -5.9 -6.8 -5.3 -5.9 -6.5 -5.5 -5.6 -5.4
9 -6.5 -8.9 -7.1 -8.4 -8.3 -8.7 -8.4 -8.4 -6.8 -6.5
10 -6.3 -8.1 -6.1 -6.6 -6.3 -6.0 -6.8 -5.5 -6.3 -5.1
11 -6.0 -7.6 -6.6 -7.5 -7.0 -6.9 -6.5 -6.9 -6.2 -6.3
12 -5.2 -7.4 -4.7 -6.2 -5.7 -6.4 -5.8 -6.4 -5.5 -5.0
13 -6.9 -10.0 -7.6 -7.6 -8.2 -7.6 -8.8 -7.7 -8.5 -7.0
14 -6.0 -6.7 -6.3 -6.4 -6.5 -6.2 -6.3 -6.3 -6.3 -6.3
Mean -5.7 -7.6 -5.9 -6.7 -6.2 -6.4 -6.5 -6.1 -6.2 -5.4
Table 9: Amino acid residues identified from the interaction of 14 ligands with
1JVY
Ligands Amino acid residues Ligands Amino acid residues
Control Lys15, Arg66, Tyr155, Asp65,
Glu153, Asp14, Glu111 8 No H-bond
1 No H-bond 9 No H-bond
2 Arg66, Arg345 10 Trp62
3 No H-bond 11 Arg66
4 Lys42 12 No H-bond
5 Asp65 13 Glu44, Arg66, Arg345
6 Glu111, Tyr155 14 Lys15
7 Trp62, Arg66
70% of  protein remains in cytoplasm49.  Ten of  them were
used as the representative target to study the molecular
mechanism   of   14  ligands  of  the  diethyl  ether  fraction.
The proteins being used as the target in E. coli were
methylerythritol phosphate cytidyltransferase (PDB 1I52)50,
maltose binding periplasmic protein (MBP; PDB 1JVY)51,
glutamine-fructose-6-phosphate  aminotransferase  (PDB
1MOS)52,   -aminobutyrate aminotransferase (PDB 1SZS)53, DNA
gyrase (PDB 4DUH)54,  enoyl  reductase (PDB 1I30)55,  isoleucyl
tRNA synthetase (PDB 1JZQ)56, aspartate aminotransferase
(PDB 1IX6)57, acetylglutamate kinase (PDB 1OHA)58 and
peptidyl   tRNA   hydroxylase  (PDB  2PTH)59.  Table  8
presented the docking results of 14 ligands identified in
diethyl  ether  fraction   against   diverse   protein   targets   in
E. coli.
As  results,  the  ligands  showed Gbind  at  range -10.7 to
-3.1 kcal molG1. According to the mean of the Gbind, the lowest
Gbind went to the interaction between Maltose Binding
Periplasmic (MBP) protein and the ligands, indicated its
strongest binding interaction among 10 protein targets.
Maltose binding periplasmic was a huge bacterial periplasmic
protein (370  amino  acid  residues)  involved  in  active
transport and chemotaxis towards maltose. This enzyme
worked under substantial conformational changes to let
maltose binds to the ATP-binding cassette (ABC)-7 transporter,
initiating downstream signaling for either transport or
chemotaxis60. Therefore, the MBP could be the selected
protein target for further study. Table 9 presented the amino
acid residues involved in the binding of 14 ligands.
From these 14 ligands, 10 of them were characterized
having hydrogen bond interaction with MBP, whereas the
remained four ligands were absent. The absent hydrogen
bond interaction might be due to incorrect pose of the polar
functional groups to interact with the nearest important
amino acid residues. Therefore, the Gbind of those compounds
were significantly contributed by hydrophobic and other Van
der Waals interactions. It was well studied that the strength of
Van der Waals interaction was weaker than hydrogen bond
interaction   due   to   their   distance   bonds,  i.e., >2.2   and
1.5-2.2 Å, respectively61.
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Fig. 8(a-c): (a) Superposition of 14 ligands in Trichaptum  sp., meanwhile inset was the pose of (b) Maltose and (c) Compound 6
at the at the binding site of  1JVY. The individual poses of maltose and compound 6  was visualized as stick forms with
carbon in yellow and standard colors of O and H. The superposition was presented in a surface protein, whereas the
individual  maltose  and  compound  6  was  performed in ribbon. The picture was visualized using discovery studio
3.5 (www.accelrys.com)
Among 10 ligands that interacted with MBP via hydrogen
bond interaction, six of them demonstrated binding modes
similar to that of control ligand (maltose) indicating their
potential to be developed as novel MBP inhibitors. The
residues being identified in their binding modes were Lys15,
Asp65, Arg66, Glu111 and Tyr155. Most of them had one
interaction  only  with  the residues, which was also a part of
the positive control’s binding mode. However, compound 6
(m-aminobenzaldehyde oxime) was identified possessing two
hydrogen bond interactions with same residues of the positive
control associating its more potential ligands to be optimized
as  MBP  inhibitors.  Figure  8  illustrated  the  superposition  of
14 ligands at the binding  site  of  MBP,  positive  control  and
the selected hit ligand-MBP molecular interaction. As
visualized  in Fig. 8c,  compound  6  showed  the  similar
binding mode towards MBP, i.e., hydrogen bond interaction
with Glu111 and Tyr155. Although there were some
interactions being  missed,  this  compound  could  be  a  good
lead model for further MBP inhibitor associating with its
potency as antibacterial against E. coli.
In silico activity against protein targets in T47D cell:
Likewise, the 14 same ligands were studied in the screening of
10 protein targets in the T47D. The protein targets were
mainly concerned on human p53 with hot spot mutation
R273C (PDB 4IBU)62 and pro-survival Bcl-2 (PDB 4B4S)63 and
NF-6B  inducing  kinase  (PDB 4DN5)64 as suggested by
previous  T47D  apoptotic  studies.  However,  it  was  tried to
seek  for  other  possibilities  in  other  protein  targets  which
were expressed in the T47D. They were: C-src tyrosine kinase
(PDB 3G5D)65, human tubulin cholcicine receptor (PDB
1SAO)66, estrogen receptor DNA binding protein (PDB
1GWQ)67,   human   oxydosqualene   cyclase   (PDB   1W6K)68,
ER nuclear receptor (PDB 3ERT)69, p38a MAP kinase (PDB
3HEG)70 and Bcl-11 (PDB 1YS1)71. Table 10 presented the
docking results of  14 ligands against  diverse  protein targets
in T47D.
Likewise, the range of Gbind for ligands against 10 protein
targets in T47D was at -11.6 to -1.3 kcal molG1. Among three
proteins which were suggested by T47D apoptotic studies,
p53  mutant  and  NF-6B  had  a  lower  Gbind  than  Bcl-2.  This
14
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impressed that two of possible mechanisms on how diethyl
ether fractions modulated the T47D apoptosis could be via
p53 and/or NF-6B inhibition. However, the evaluation on
docking results was not obviously based on the Gbind since
frequently, the lower docking score was majorly contributed
by Van der Waals interaction as mentioned before. The p53
mutant with PDB 4IBU was a human p53 mutant with hot spot
R273C in complex with zinc ion, ethylene glycol and acetate
ion, meanwhile NF-6B with PDB 4DN5 was a human NF-6B
kinase in complex with phosphothiophosphoric-acid adenilate
ester. Based on the structure of both crystallized ligands, the
compounds identified in diethyl ether fraction seemed like no
similar pharmacophoric features with them. The probability of
compounds bound to the allosteric site of enzyme was there,
but here, it was firstly focused on the active site. Hence, it was
tried to seek for other protein which had a crystallized ligand
mimicking the compounds presenting in the diethyl ether
fraction.
Apparently, human oxydosqualene cyclase (PDB 1W6K)
was identified having the lowest value in the mean of Gbind 
among  all  14  ligands.  Again,  this  indicated  its  potential  to
be  the  protein  target  in  blocking  T47D  cell growth.  Human 
oxydosqualene cyclase (OSC) is a membrane-bound enzyme,
which catalyzes the formation of lanosterol, a precursor to
synthesize human colesterol72. Human cholesterol from
lanosterol is a sterol isomerase, known to be modulated by
several well known sterol biosynthesis inhibitor such as
tamoxifen,  a  chemotherapeutic  agent  for  breast  cancer.
Table 11 presented the amino acid residues involved in the
binding of  14 ligands-OSC.
The control ligand (lanosterol) only showed one hydrogen
bond  interaction  with  Asp455.  The  major   contributor  in
this  ligand-protein  interaction  was  hydrophobic  character
of    steroid    scaffold    surrounded    by   non-polar   amino
acid   residues   such   as   Phe444,   Phe521,  Ile524,  Phe696
and   Ile702.   One   ligand,   i.e.,  compound  3  demonstrated
a  similar  pose  with  the  control  ligand  due  to  the
interaction with Asp455 via hydrogen bonding. This was
because  they  beard  a  same  steroid-based  scaffold.
Therefore,  this  compound  indicated  its  potency   as  the
lead for further optimization as OSC inhibitor. Figure 9
illustrated the superposition of 14 ligands at the binding site
of  the human OSC and the most active ligand-OSC molecular
interaction.
Fig. 9(a-c): (a)   Superposition   of   14   ligands   in   Trichaptum   sp.,   meanwhile   inset  was  the  pose  of  (b)  Lanosterol   and
(c) Compound 3 at the at the binding site of  1W6K. The individual poses of lanosterol and compound 3 was
visualized as stick forms with carbon in yellow and standard colors of O and H. The superposition was presented in
a surface protein, whereas the individual maltose and compound 6 was performed in ribbon. The picture was
visualized using discovery studio 3.5 (www.accelrys.com)
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Table 10: Gbinding of 14 ligands were docked into proteins in and T47D cell lines
Gbind (kcal molG1)
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Ligands 1IBU 4B4S 4DN5 1SA0 3G5D 1GWQ 1W6K 3ERT 3HEG 1YS1
1 -4.4 -3.9 -5.6 -5.6 -5.6 -6.0 -7.0 -5.8 -5.7 -5.9
2 -4.6 -4.2 -5.9 -5.9 -5.8 -6.0 -7.7 -5.9 -6.3 -6.1
3 -6.9 -5.5 -8.9 -1.3 -7.7 -7.3 -11.6 -7.6 -7.5 -8.3
4 -5.8 -6.1 -6.5 -9.4 -8.3 -6.0 -10.6 -6.2 -7.2 -8.3
5 -4.1 -3.8 -5.5 -5.4 -5.5 -5.5 -6.2 -5.7 -5.3 -5.4
6 -5.5 -4.8 -6.0 -5.5 -5.5 -6.2 -6.4 -6.1 -5.7 -5.6
7 -3.5 -3.1 -3.3 -3.5 -3.1 -3.4 -3.7 -3.4 -3.3 -3.3
8 -5.5 -4.8 -6.2 -5.9 -6.6 -5.5 -7.5 -6.7 -6.0 -5.7
9 -5.5 -5.6 -8.8 -7.7 -8.4 -8.3 -10.3 -8.4 -7.2 -8.3
10 -5.0 -4.0 -6.6 -5.9 -7.0 -7.0 -8.5 -7.3 -6.8 -6.7
11 -5.2 -6.0 -7.2 -6.4 -6.9 -7.0 -8.3 -7.1 -6.3 -6.9
12 -4.0 -4.4 -6.7 -5.5 -6.2 -6.2 -7.4 -6.5 -6.2 -6.1
13 -6.7 -5.6 -8.7 -5.6 -5.6 -7.6 -10.7 -8.3 -7.3 -8.0
14 -5.4 -5.0 -6.4 -5.9 -5.8 -6.7 -7.3 -6.4 -5.7 -6.2
Mean -5.15 -4.8 -6.6 -4.3 -6.3 -6.3 -8.1 -6.5 -6.2 -6.5
Table 11: Amino acid residues identified from the interaction of 14 ligands with
1W6K
Ligands Amino acid residues Ligands Amino acid residues
Control Asp455 8 Tyr704
1 His232, Ser339 9 No H-bond
2 His232, Ser339, Ile338 10 Tyr504, Tyr704
3 Asp455 11 His232
4 His232 12 No H-bond
5 No H-bond 13 Tyr98, Tyr503, 
6 Gly380 14 Tyr98
7 No H-bond
CONCLUSION
A fungal endophyte of Trichaptum sp., genus isolated
from Phyllantus  niruri  in organic fractions such as n-hexane,
diethyl ether and ethanol 96% was studied in a various
biological activities as antimicrobial, antioxidant and cytotoxic
agent against breast cancer cell. Diethyl ether was selected as
the most active fractions inhibiting the representative bacteria
cell growth and T47D breast cancer cell lines, whereas ethanol
96% was found as the most active antioxidant. It was observed
that E.  coli   was the most sensitive bacteria against the diethyl
ether fraction. Further T47D cell assay revealed that the diethyl
ether fraction served as cancer cytotoxic agent by modulating
cell arrest as well as its apoptosis. The suggested proteins
being involved in this molecular mechanism were p53, Bcl-2
and NF-6B. In this study, we have a limitation in testing the
activity of the fractions against E.  coli   and T47D breast cancer
cell lines at enzyme or receptor level. This restricted more
understanding of molecular mechanism on how fungal
endophyte from Phyllantus niruri served as antibacterial as
well as anticancer. However, it was initiated to study the
molecular mechanism of some representatives compounds
identified in the diethyl ether fraction against diverse protein
targets in E. coli as well as T47D breast cancer cell lines. This
was aimed to guide our further experiment in isolating
compounds from the corresponding endophyte and testing
them against the selected protein targets. The docking studies
showed that compounds bearing benzaldehyde oxime were
potential for maltose binding periplasmic associating with
their potencies as an antibacterial agent. Beside, compounds
bearing steroid is also potential for human OSC inhibitor due
to its disclose scaffold with the control ligand of human OSC.
Overall,  the  novelty  of  this  study  is  the  discovery  of
Trichaptum sp., in a fungal endophyte genus isolated and
cultivated from Phyllantus  niruri  which never been reported.
Moreover, the organic fractions this endophyte is found active
as antibacterial, antioxidant and T47D breast cancer cytotoxic
agent. Further study would be emphasized on in vitro MBP
and OSC inhibition assay by diethyl ether fraction to prove the
concept of molecular docking.
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